GTPBP6

gene
On this page

Also known as PGPLFLJ20977

Summary

GTPBP6 (GTP binding protein 6, HGNC:30189) is a protein-coding gene on chromosome Xp22.33 and Yp11.32, encoding Putative GTP-binding protein 6 (O43824).

This gene encodes a GTP binding protein and is located in the pseudoautosomal region (PAR) at the end of the short arms of the X and Y chromosomes.

Source: NCBI Gene 8225 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_012227

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30189
Approved symbolGTPBP6
NameGTP binding protein 6
LocationXp22.33 and Yp11.32
Locus typegene with protein product
StatusApproved
AliasesPGPL, FLJ20977
Ensembl geneENSG00000178605
Ensembl biotypeprotein_coding
OMIM300124
Entrez8225

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 7 protein_coding, 1 retained_intron

ENST00000326153, ENST00000485332, ENST00000850592, ENST00000900013, ENST00000900014, ENST00000900015, ENST00000914511, ENST00000966877

RefSeq mRNA: 1 — MANE Select: NM_012227 NM_012227

CCDS: CCDS75943

Canonical transcript exons

ENST00000326153 — 10 exons

ExonStartEnd
ENSE00001288218311419311627
ENSE00001793174312766312924
ENSE00003449454314150314217
ENSE00003581203307360307512
ENSE00003654058307732307880
ENSE00003714129314890315020
ENSE00003733507316914317051
ENSE00003733593315229315299
ENSE00004282261304759305197
ENSE00004282262318439318796

Expression profiles

Bgee: expression breadth ubiquitous, 251 present calls, max score 95.74.

Top tissues by expression

279 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left ovaryUBERON:000211995.74gold quality
right ovaryUBERON:000211895.70gold quality
right hemisphere of cerebellumUBERON:001489095.68gold quality
tibial nerveUBERON:000132395.01gold quality
body of stomachUBERON:000116194.93gold quality
gastrocnemiusUBERON:000138894.87gold quality
body of uterusUBERON:000985394.82gold quality
sural nerveUBERON:001548894.59gold quality
cerebellar hemisphereUBERON:000224594.55gold quality
esophagogastric junction muscularis propriaUBERON:003584194.45gold quality
cerebellar cortexUBERON:000212994.42gold quality
left uterine tubeUBERON:000130394.30gold quality
lower esophagus muscularis layerUBERON:003583394.24gold quality
right uterine tubeUBERON:000130294.22gold quality
lower esophagusUBERON:001347394.22gold quality
left coronary arteryUBERON:000162694.17gold quality
muscle of legUBERON:000138394.13gold quality
right lobe of thyroid glandUBERON:000111994.07gold quality
metanephros cortexUBERON:001053394.07gold quality
body of pancreasUBERON:000115094.04gold quality
hindlimb stylopod muscleUBERON:000425294.02gold quality
endocervixUBERON:000045894.01gold quality
left lobe of thyroid glandUBERON:000112093.98gold quality
right lungUBERON:000216793.96gold quality
popliteal arteryUBERON:000225093.96gold quality
tibial arteryUBERON:000761093.95gold quality
right atrium auricular regionUBERON:000663193.90gold quality
C1 segment of cervical spinal cordUBERON:000646993.84gold quality
mucosa of transverse colonUBERON:000499193.77gold quality
muscle layer of sigmoid colonUBERON:003580593.77gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

8 targeting GTPBP6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-450599.2767.812678
HSA-MIR-578799.2267.862628
HSA-MIR-797798.6566.182590
HSA-MIR-609091.0162.65222

Literature-anchored findings (GeneRIF, showing 1)

  • Dual function of GTPBP6 in biogenesis and recycling of human mitochondrial ribosomes. (PMID:33264405)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriogtpbp6ENSDARG00000061091
mus_musculusGtpbp6ENSMUSG00000033434
rattus_norvegicusGtpbp6ENSRNOG00000062521
drosophila_melanogasterCG5116FBGN0039339

Protein

Protein identifiers

Putative GTP-binding protein 6O43824 (reviewed: O43824)

Alternative names: Pseudoautosomal GTP-binding protein-like

All UniProt accessions (1): O43824

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Ubiquitously expressed.

Miscellaneous. The gene coding for this protein is located in the pseudoautosomal region 1 (PAR1) of X and Y chromosomes.

Similarity. Belongs to the TRAFAC class OBG-HflX-like GTPase superfamily. HflX GTPase family.

RefSeq proteins (1): NP_036359* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006073GTP-bdDomain
IPR016496GTPase_HflXFamily
IPR025121GTPase_HflX_NDomain
IPR027417P-loop_NTPaseHomologous_superfamily
IPR030394G_HFLX_domDomain
IPR032305GTP-bd_MDomain
IPR042108GTPase_HflX_N_sfHomologous_superfamily

Pfam: PF01926, PF13167, PF16360

UniProt features (18 total): binding site 7, sequence conflict 5, compositionally biased region 3, chain 1, domain 1, region of interest 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
7OF6ELECTRON MICROSCOPY2.6
7OF2ELECTRON MICROSCOPY2.7
7OF4ELECTRON MICROSCOPY2.7

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O43824-F177.920.38

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (7): 349–352; 418–421; 437–439; 301–308; 308; 327–331; 329

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 98 (showing top): GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP, GOBP_RIBOSOME_BIOGENESIS, GOBP_RIBOSOME_ASSEMBLY, GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN, SANSOM_APC_TARGETS_REQUIRE_MYC, NUYTTEN_NIPP1_TARGETS_DN, MODULE_159, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING, GOMF_RIBOSOME_BINDING

GO Biological Process (1): mitochondrial large ribosomal subunit assembly (GO:1902775)

GO Molecular Function (5): GTP binding (GO:0005525), ribosome binding (GO:0043022), ribosomal large subunit binding (GO:0043023), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)

GO Cellular Component (2): cytoplasm (GO:0005737), mitochondrion (GO:0005739)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
ribosomal large subunit assembly1
mitochondrial ribosome assembly1
guanyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
ribonucleoprotein complex binding1
ribosome binding1
cation binding1
nucleoside phosphate binding1
heterocyclic compound binding1
intracellular anatomical structure1
cellular anatomical structure1
cytoplasm1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1694 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GTPBP6GTPBP4Q9BZE4832
GTPBP6MALSU1Q96EH3769
GTPBP6GTPBP10A4D1E9763
GTPBP6PLCXD1Q9NUJ7754
GTPBP6MTG2Q9H4K7747
GTPBP6ASMTLO95671728
GTPBP6PPP2R3BQ9Y5P8698
GTPBP6DDX28Q9NUL7691
GTPBP6MTG1Q9BT17690
GTPBP6GTPBP8Q8N3Z3667
GTPBP6AKAP17AQ02040666
GTPBP6DHRSXQ8N5I4630
GTPBP6MTERF4Q7Z6M4616
GTPBP6NSUN4Q96CB9602
GTPBP6MRRFQ96E11595

IntAct

44 interactions, top by confidence:

ABTypeScore
CD79AMETTL15psi-mi:“MI:0914”(association)0.530
SDF4GTPBP6psi-mi:“MI:0914”(association)0.530
BPNT1GTPBP10psi-mi:“MI:0914”(association)0.530
YBEYNME4psi-mi:“MI:0914”(association)0.530
PSME1POLR3Apsi-mi:“MI:0914”(association)0.530
ATP5F1DNDUFB5psi-mi:“MI:0914”(association)0.530
EMILIN1METTL15psi-mi:“MI:0914”(association)0.530
ZNRD2CCDC85Cpsi-mi:“MI:0914”(association)0.530
GTPBP6RPL24psi-mi:“MI:0915”(physical association)0.400
Rpl35RPS6psi-mi:“MI:0914”(association)0.350
RIPK4VWA8psi-mi:“MI:0914”(association)0.350
ESR1ESYT2psi-mi:“MI:0914”(association)0.350
MRPL12psi-mi:“MI:0914”(association)0.350
AP3B1psi-mi:“MI:0914”(association)0.350
ATG16L1ESYT2psi-mi:“MI:0914”(association)0.350
ATG16L1psi-mi:“MI:0914”(association)0.350
HLA-DRATMEM223psi-mi:“MI:0914”(association)0.350
PIPSLC1orf226psi-mi:“MI:0914”(association)0.350
LURAP1CIBAR1psi-mi:“MI:0914”(association)0.350
MAGEA9CIBAR1psi-mi:“MI:0914”(association)0.350
FAXCMETTL15psi-mi:“MI:0914”(association)0.350
DGCR2CCDC85Cpsi-mi:“MI:0914”(association)0.350
DKK3MYO9Apsi-mi:“MI:0914”(association)0.350
THBS3APBB1psi-mi:“MI:0914”(association)0.350
MRPS17POLRMTpsi-mi:“MI:0914”(association)0.350
MRPL23GTPBP6psi-mi:“MI:0914”(association)0.350

BioGRID (86): GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-RNA), GTPBP6 (Affinity Capture-RNA), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS)

ESM2 similar proteins: A0A1B3PEJ0, A0A2K3DU55, A2XFU5, A2XU53, A2YQ58, A4HUY0, A4I1F7, A4RPM5, A8I2V9, B6TN12, B8A031, B8AA76, B8B016, B9FK36, C0PN26, C5XKZ1, C5Y9R0, E1BRE2, E2RDZ6, O43824, P18080, P52506, P52507, P84172, Q0D3F2, Q0J705, Q10MI9, Q2KIF8, Q2KNB4, Q2QMG2, Q3U6U5, Q5AQE4, Q5R6G3, Q5ZAQ2, Q5ZHX9, Q6H4G3, Q6L534, Q6NZB1, Q6Z4A7, Q74ZW4

Diamond homologs: A0L4B2, A0LPF9, A1RY30, A2BLW4, A5EY43, A5GNK6, A5IKX2, A6H294, A6TQJ6, A7HIF8, A8FRU4, A9A623, A9H253, B0K414, B0KAB8, B0T310, B1I5V8, B1KGH1, B1LA53, B1ZZ37, B2FNR1, B2U9V3, B2UPE7, B3QZ96, B3R1J8, B4RD64, B4SSW8, B4UIU2, B5EJF7, B7JC34, B8FUR9, B8I179, B8JBP2, B9DNE7, B9KZ43, C0QLE9, C1F407, C5BLV6, C6E2H7, D3FTV4

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 57 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Translation610.6×4e-03

GO biological processes:

GO termPartnersFoldFDR
translation612.3×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

761 predictions. Top by Δscore:

VariantEffectΔscore
X:305211:CGCGT:Cacceptor_gain1.0000
X:305213:CGT:Cacceptor_gain1.0000
X:305215:T:Cacceptor_gain1.0000
X:305215:T:TCacceptor_gain1.0000
X:307355:CTCA:Cdonor_loss1.0000
X:307356:TCA:Tdonor_loss1.0000
X:307357:CACCT:Cdonor_loss1.0000
X:307358:AC:Adonor_loss1.0000
X:307728:TCA:Tdonor_loss1.0000
X:307729:CACCC:Cdonor_loss1.0000
X:307730:AC:Adonor_gain1.0000
X:307731:CC:Cdonor_gain1.0000
X:305194:CCAG:Cacceptor_gain0.9900
X:305195:CAGC:Cacceptor_gain0.9900
X:305196:A:Tacceptor_gain0.9900
X:305205:CAGA:Cacceptor_gain0.9900
X:305208:A:ACacceptor_gain0.9900
X:305208:A:Cacceptor_gain0.9900
X:305214:G:GCacceptor_gain0.9900
X:305217:G:GCacceptor_gain0.9900
X:305219:A:ACacceptor_gain0.9900
X:305219:A:Cacceptor_gain0.9900
X:307508:TGTAC:Tacceptor_gain0.9900
X:307510:TAC:Tacceptor_gain0.9900
X:307511:AC:Aacceptor_gain0.9900
X:307512:CC:Cacceptor_gain0.9900
X:307513:C:CCacceptor_gain0.9900
X:307513:C:CGacceptor_loss0.9900
X:307514:T:Cacceptor_loss0.9900
X:307730:A:ACdonor_gain0.9900

AlphaMissense

6586 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
Y:311563:A:CF327L0.993
Y:311563:A:TF327L0.993
Y:311565:A:GF327L0.993
Y:311449:G:CF365L0.992
Y:311449:G:TF365L0.992
Y:311451:A:GF365L0.992
Y:305181:C:GA482P0.991
Y:311485:G:CF353L0.991
Y:311485:G:TF353L0.991
Y:311487:A:GF353L0.991
Y:307749:C:AK419N0.989
Y:307749:C:GK419N0.989
Y:311486:A:GF353S0.989
Y:312780:C:TG301E0.989
Y:315266:A:TV174D0.989
Y:311565:A:TF327I0.988
Y:311627:C:TG306E0.988
Y:311564:A:CF327C0.985
Y:311627:C:AG306V0.985
Y:312781:C:GG301R0.985
Y:312781:C:TG301R0.985
Y:315002:A:GW193R0.985
Y:315002:A:TW193R0.985
Y:317031:C:GA124P0.985
Y:305174:A:TV484D0.984
Y:311499:C:GD349H0.984
Y:311623:C:AK307N0.984
Y:311623:C:GK307N0.984
Y:314944:G:TA212D0.984
Y:311498:T:AD349V0.983

dbSNP variants (sampled 300 via entrez): RS1000079997 (X:307386 A>G), RS1000157476 (X:310832 A>G), RS1000637681 (X:310951 G>A,C), RS1000675767 (X:306377 C>T), RS1001171690 (X:306183 G>A), RS1001798100 (X:306138 A>C,G), RS1002005441 (X:309641 C>T), RS1002516783 (X:309382 T>C), RS1002580836 (X:313229 C>T), RS1002909325 (X:305375 G>A,C), RS1002940360 (X:305481 C>G), RS1003112505 (X:308590 G>A,C), RS1003427511 (X:308774 A>G), RS1004146563 (X:308515 C>T), RS1005802417 (X:304472 A>G,T)

Disease associations

OMIM: gene MIM:300124 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
chromium hexavalent ionincreases expression, decreases expression, increases abundance2
Cadmium Chlorideincreases expression2
trichostatin Aaffects expression1
zinc chromatedecreases expression, increases abundance1
potassium chromate(VI)increases expression1
cupric chlorideincreases expression1
nickel sulfateincreases expression1
2,3-dimethoxy-1,4-naphthoquinoneincreases expression1
theaflavin-3,3’-digallateaffects expression1
Air Pollutantsincreases abundance, affects expression1
Antimonyincreases expression1
Antimony Potassium Tartrateincreases expression1
Cadmiumincreases expression1
Cisplatindecreases expression1
Estradioldecreases expression1
Methyl Methanesulfonatedecreases expression1
Ouabainincreases expression1
Ozoneaffects expression, increases abundance1
Potassium Dichromateincreases expression1
Ribonucleotidesaffects binding1
Smokedecreases expression1
Toluenedecreases methylation, increases expression1
Valproic Acidincreases methylation1
Sodium Seleniteincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.